Echothiophate for Lazy Eye

This trial explores whether echothiophate iodide can treat children with stubborn lazy eye (amblyopia) that hasn't improved with common treatments like atropine eye drops. Researchers aim to determine if adding echothiophate iodide can restart progress in children who have stopped improving and if it is more effective for older kids and teens. The trial will also assess whether the medicine enhances depth perception, vision in crowded places, and motion detection. Children with lazy eye who have used atropine without improvement might be suitable candidates for this study. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group, offering a chance to contribute to important findings.

The trial does not specify if you need to stop taking your current medications, but you must already be using atropine eye drops and cannot use other anticholinesterase medications during the study.

Research shows that echothiophate iodide, the treatment tested in this trial, has been used previously in eye care. It helps with certain eye conditions by keeping the eyes aligned and preventing lazy eye from worsening. Past studies have found echothiophate iodide effective in lowering intraocular pressure in most cases.

However, some side effects have been reported. Common ones include eye irritation, brow ache, and redness of the eye. Some people also experience blurred vision after using the drops. Despite these side effects, the treatment has been used safely for other eye conditions, indicating it is generally well-tolerated.

Unlike the standard treatments for lazy eye, such as patching or using atropine alone, Echothiophate Iodide in combination with atropine offers a fresh approach. Echothiophate works by enhancing the effects of acetylcholine, which can help improve eye muscle function more effectively. Researchers are excited about this treatment because it could provide a more robust and faster correction of vision issues associated with lazy eye compared to traditional methods, potentially leading to better outcomes for patients.

Research has shown that echothiophate iodide can help treat refractory amblyopia, commonly known as lazy eye. Past studies have successfully used this medication in children, improving vision in difficult-to-treat cases. It strengthens the weaker eye, leading to better overall vision. Echothiophate has also proven effective for other eye conditions, supporting its potential use for amblyopia. Although specific data for amblyopia remain limited, these early findings offer promise for patients who do not respond well to other treatments. Participants in this trial will receive a combination therapy of Atropine and Echothiophate to evaluate its effectiveness for amblyopia.¹²⁴⁶⁷